Antares Pharma
ATRS
#5529
Rank
S$1.24 B
Marketcap
$7.28
Share price
0.00%
Change (1 day)
21.62%
Change (1 year)

Revenue for Antares Pharma (ATRS)

Revenue in 2021: S$0.23 B

According to Antares Pharma's latest financial reports the company's current revenue (TTM) is S$0.23 B. In 2021 the company made a revenue of S$0.23 B an increase over the revenue in the year 2020 that were of S$0.19 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Antares Pharma from 1996 to 2021

Annual revenue

Year Revenue Change
2021S$0.23 B22.98%
2020S$0.19 B20.78%
2019S$0.16 B94.9%
2018S$82.78 M16.58%
2017S$71 M4.39%
2016S$68.02 M14.38%
2015S$59.47 M72.28%
2014S$34.51 M28.53%
2013S$26.85 M-8.67%
2012S$29.4 M37.17%
2011S$21.43 M28.39%
2010S$16.69 M54.24%
2009S$10.82 M46.82%
2008S$7.37 M-27.95%
2007S$10.23 M84.07%
2006S$5.55 M91.86%
2005S$2.89 M-18.98%
2004S$3.57 M-27.49%
2003S$4.93 M-5.23%
2002S$5.2 M14.21%
2001S$4.55 M75.52%
2000S$2.59 M-42.75%
1999S$4.53 M26.57%
1998S$3.58 M-25.99%
1997S$4.84 M0.68%
1996S$4.8 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$0.70 B 192.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$25.82 B 10,677.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.74 B 1,463.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$49.82 M-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$72.47 B 30,143.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$21.21 B 8,754.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
S$112.76 B 46,956.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$50.69 B 21,055.77%๐Ÿ‡บ๐Ÿ‡ธ USA